Search Results 471-480 of 16282 for pharmacogenetics
Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...
About this study. The purpose of this study is to use samples from multiple patients to validate and provide detailed mapping of food to identify allergen ...
About this study. This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, ...
Scottsdale/Phoenix, Ariz. This is an efficacy and safety study of grazoprevir (MK-5172) in combination with elbasvir (MK-8742) with or without ribavirin (RBV) ...
The purpose of this study is to develop an AI-driven biomarker based on FDG-PET images to track longitudinal brain changes in asymptomatic (n = 15) and ...
Shahi M, Katsakhyan L, Hopkins M, Allen-Rhoades W, Cepress MK, Langstraat C, Ishitani MB, Vang R, Ronnett BM, Xing D. Ovarian non-gestational placental site ...
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
About this study. The purpose of this study evaluates a subset of people with isolated Impaired Fasting Glucose with Normal Glucose Tolerance (i.e., ...
The long term research goal and objective of this application is to improve the clinical outcomes of patients with biliary tract cancers and germ cell tumors.
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.